Regression of advanced non-splenic marginal zone lymphoma after treatment of hepatitis C virus infection | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Regression of advanced non-splenic marginal zone lymphoma after treatment of hepatitis C virus infection

Svoboda J, Andreadis C, Downs LH, Miller WT, Tsai DE, Schuster SJ. Regression of advanced non-splenic marginal zone lymphoma after treatment of hepatitis C virus infection. Leuk Lymphoma. 2005;46(9):1365-1368.

Publication Type:

Journal Article

Authors:

Svoboda, J.; Andreadis, C.; Downs, L.H.; W T Miller; Tsai, D.E.; Schuster, S.J.

Source:

Leuk Lymphoma, Volume 46, Issue 9, p.1365-1368 (2005)

Keywords:

Bone Marrow, Case Report, complications, drug therapy, Drug Therapy,Combination, HCV, hepatitis, Hepatitis C, hepatitis C virus, Humans, Infection, interferon, Interferons, Liver, Liver Neoplasms, Lymph Nodes, Lymphatic Metastasis, Lymphoid Tissue, Lymphoma, Lymphoma,B-Cell,Marginal Zone, Male, Middle Aged, Patients, peginterferon, Philadelphia, Ribavirin, Salivary Gland Neoplasms, secondary, testing, therapeutic use, treatment

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/16109616

Export Citation:

RIS Format

Top